FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ORANTINIB
异名/同义词1H-PYRROLE-3-PROPANOIC ACID, 5-((1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-
3-(2,4-DIMETHYL-5-(((3Z)-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-1H-PYRROL-3-YL)PROPANOIC ACID
3-(2,4-DIMETHYL-5-((2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-1H-PYRROL-3-YL)PROPIONIC ACID
3-(2,4-DIMETHYL-5-(2-OXO-1,2-DIHYDROINDOL-3-YLIDENEMETHYL)-1H-PYRROL-3-YL)PROPIONIC ACID
3-(4-(2-CARBOXYETHYL)-3,5-DIMETHYLPYRROL-2-METHYLIDENYL)-2-INDOLINONE
5-((1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-1H-PYRROLE-3-PROPANOIC ACID
NSC-702827
ORANTINIB
ORANTINIB [INN]
ORANTINIB [WHO-DD]
SU006668
SU-006668
SU-6668
TSU-68
CAS登记号252916-29-3
物质唯一标识(Unique Ingredient Identifier)9RL37ZZ665
分子式C18H18N2O3
国际化合物标识(International Chemical Identifier,InChI)NHFDRBXTEDBWCZ-ZROIWOOFSA-N
SMILESCc1c(CCC(=O)O)c(C)[nH]c1/C=C\2/c3ccccc3NC2=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System